Literature DB >> 17591605

Kidney disease management in UK primary care: guidelines, incentives and information technology.

Bernhard Klebe1, Chris Farmer, Roger Cooley, Simon de Lusignan, Rachel Middleton, Donal O'Donoghue, John New, Paul Stevens.   

Abstract

The last few years have seen new developments to understand and tackle the significant public health issue posed by chronic kidney disease (CKD). Established renal disease currently consumes 2% of the UK National Health Service budget and predictions are that this figure will increase significantly due to the rising number of people requiring renal replacement therapy fuelled by the ageing population and the diabetes mellitus epidemic. This paper reviews the scale of CKD and discusses the new developments such as staging, referral guidelines and new Department of Health incentives brought about to improve awareness. The importance of Information Technology in assisting the management of renal disease is also outlined. We identify various types of intervention which might be used to do this: feedback in an educational context, the establishment of computerized decision support and enhancement of the patient journey. Many principles may be extended to the management of any chronic disease. While new developments are necessary to improve care, wider implementation is required to be able to see if improved outcomes are achieved.

Entities:  

Mesh:

Year:  2007        PMID: 17591605     DOI: 10.1093/fampra/cmm026

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  6 in total

Review 1.  Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review.

Authors:  Hugh Gallagher; Simon de Lusignan; Kevin Harris; Christopher Cates
Journal:  Br J Gen Pract       Date:  2010-06       Impact factor: 5.386

2.  A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial.

Authors:  Brendan J Barrett; Amit X Garg; Ron Goeree; Adeera Levin; Anita Molzahn; Claudio Rigatto; Joel Singer; George Soltys; Steven Soroka; Dieter Ayers; Patrick S Parfrey
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 8.237

3.  Recommendations for a clinical decision support for the management of individuals with chronic kidney disease.

Authors:  Meenal B Patwardhan; Kensaku Kawamoto; David Lobach; Uptal D Patel; David B Matchar
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

4.  Referral and management options for patients with chronic kidney disease: perspectives of patients, generalists and specialists.

Authors:  Charlotte Wilson; Stephen M Campbell; Karen A Luker; Ann-Louise Caress
Journal:  Health Expect       Date:  2012-12-10       Impact factor: 3.377

5.  Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.

Authors:  Danielle E Robinson; M Sanni Ali; Victoria Y Strauss; Leena Elhussein; Bo Abrahamsen; Nigel K Arden; Yoav Ben-Shlomo; Fergus Caskey; Cyrus Cooper; Daniel Dedman; Antonella Delmestri; Andrew Judge; Muhammad Kassim Javaid; Daniel Prieto-Alhambra
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

6.  Evaluating the implementation strategy for estimated glomerular filtration rate reporting in Manitoba: the effect on referral numbers, wait times, and appropriateness of consults.

Authors:  Jay Hingwala; Sandip Bhangoo; Brett Hiebert; Manish M Sood; Claudio Rigatto; Navdeep Tangri; Paul Komenda
Journal:  Can J Kidney Health Dis       Date:  2014-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.